Dina Lynch

Dina Lynch serves as the Vice President of Market Access and Reimbursement at Renibus Therapeutics Inc, where the focus is on building this key department for a commercial-stage biopharmaceutical company dedicated to improving outcomes for cardiothoracic surgical patients. Prior to this role, Dina held positions including Vice President at Alzheon, Inc., and Vice President of Sales & Managed Care at Nabriva Therapeutics plc, where responsibilities included creating market access and managed care strategies. Additionally, Dina has a history of establishing market access departments at companies such as Otonomy, Inc., and Optimer Pharmaceuticals, while also contributing significant expertise in health policy and reimbursement strategies at organizations like Eisai and Genentech. Dina holds an MBA from North Central College and a BA in Business Administration and Management from Augustana College.